CD8A and neoplasm: In the patient-derived xenograft (PDX) model, CD8+ T cells transfected with NKILA shRNA were implanted into immunocompromised mice, which effectively inhibited the tumor growth and overcame tumor immune evasion by increasing infiltration and cytotoxicity of CLTs and decreasing the AICDs [103].